Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed Price. Currency in USD
28.94-0.33 (-1.14%)
At close: 3:59 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close29.27
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap202.24B
P/E Ratio (ttm)21.73
Avg Vol (3m)996,729
Dividend & Yield1.02 (3.48%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist14 hours ago

    How Did Roche’s HER2 Franchise Perform in 3Q16?

    Roche’s (RHHBY) HER2+ (human epidermal growth factor receptor 2-positive) franchise includes its blockbuster drug, Herceptin, as well as Perjeta and Kadcyla.

  • Market Realist16 hours ago

    How Did Roche’s Pharmaceuticals Division Perform?

    During the third quarter of 2016, Roche (RHHBY) witnessed 1% growth in the US compared with 3Q15.

  • Market Realist17 hours ago

    Roche’s Disappointing 3Q16 Earnings

    Roche Holding (RHHBY) reported earnings for 3Q16 on October 20, 2016. Wall Street analysts expected Roche to report 12.6 billion Swiss francs in revenue during 3Q16 while the company reported ~12.5 billion ...